Recombinant Technology Driving Next-Gen Avian Influenza Defense 2026
The Strategic Shift to Genetically Engineered Protection
The global fight against rapidly mutating avian pathogens, especially highly pathogenic Avian Influenza (AI), is undergoing a strategic shift towards Recombinant Vector Vaccines. These advanced products use genetic engineering to insert specific genes from a target...